Marksans Pharma Schedules Q2FY27 Earnings Conference Call for 5th Nov'26
Marksans Pharma Ltd 路 Intimation 路 05 Nov 2026, 4:00 pm
Marksans Pharma Schedules Q2FY27 Earnings Conference Call for 5th Nov'26 Marksans Pharma Ltd. has scheduled its Q2FY27 earnings conference call on 5th Nov'26 at 04:00 PM IST to discuss unaudited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26. The call will be hosted by Systematix Institutional Equities, with executive representation from Founder, Chairman, and MD Mark Saldanha, alongside CFO Jitendra Sharma. Presentation materials, audio recordings, and transcripts will be made available on the company's official website post-event.
Original exchange filing (PDF)
More announcements from Marksans Pharma Ltd
- Transcript of Investors/Analyst meet on Q2 FY27 Financial Results 路 13 Nov 2026
- Audio Recording of investor(s)/analyst(s) meet Conference Call on Q2 FY 27 Financial Results 路 05 Nov 2026
- Allotment of Equity Shares under Marksans Employees Stock Option Scheme 2024 路 04 Nov 2026
- Press Release for Financial Results Q2FY27 路 04 Nov 2026
- Investor Presentation Q2FY27 路 04 Nov 2026
- Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended 30 September 2026 路 04 Nov 2026
- Marksans Pharma Limited has submitted to the Exchange, unaudited financial results for the quarter and half year ended September 30, 2026. 路 04 Nov 2026
- Please find attached outcome of the Board meeting held on 04 November 2026 路 04 Nov 2026
